Chemicals - Specialty
Build Your Comparison
Side-by-side financial analysisStock Comparison
PRM vs IOSP vs BCPC vs ASIX
Revenue, margins, valuation, and 5-year total return — side by side.
Chemicals - Specialty
Chemicals - Specialty
Chemicals
PRM vs IOSP vs BCPC vs ASIX — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Chemicals - Specialty | Chemicals - Specialty | Chemicals - Specialty | Chemicals |
| Market Cap | $5.79B | $2.13B | $5.29B | $615M |
| Revenue (TTM) | $706M | $1.79B | $1.06B | $1.55B |
| Net Income (TTM) | $-190M | $114M | $158M | $10M |
| Gross Margin | 56.4% | 27.4% | 36.3% | 7.4% |
| Operating Margin | -20.5% | 8.1% | 21.0% | 0.7% |
| Forward P/E | 20.3x | 17.9x | 31.5x | 15.9x |
| Total Debt | $34M | $90M | $192M | $383M |
| Cash & Equiv. | $326M | $293M | $75M | $20M |
PRM vs IOSP vs BCPC vs ASIX — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Nov 21 | Jun 26 | Return |
|---|---|---|---|
| Perimeter Solutions… (PRM) | 100 | 301.9 | +201.9% |
| Innospec Inc. (IOSP) | 100 | 106.6 | +6.6% |
| Balchem Corporation (BCPC) | 100 | 104.5 | +4.5% |
| AdvanSix Inc. (ASIX) | 100 | 50.4 | -49.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: PRM vs IOSP vs BCPC vs ASIX
Each card shows where this stock fits in a portfolio — not just who wins on paper.
PRM is the #2 pick in this set and the best alternative if growth exposure and long-term compounding is your priority.
- Rev growth 16.4%, EPS growth -32.8%, 3Y rev CAGR 21.9%
- 195.6% 10Y total return vs BCPC's 180.9%
- 16.4% revenue growth vs IOSP's -3.7%
- +164.1% vs ASIX's -4.2%
IOSP is the clearest fit if your priority is valuation efficiency.
- PEG 0.56 vs ASIX's 8.46
- Lower P/E (17.9x vs 31.5x), PEG 0.56 vs 2.46
BCPC carries the broadest edge in this set and is the clearest fit for income & stability and sleep-well-at-night.
- Dividend streak 16 yrs, beta 0.26, yield 0.5%
- Lower volatility, beta 0.26, Low D/E 15.3%, current ratio 2.07x
- 15.0% margin vs PRM's -26.9%
- Beta 0.26 vs PRM's 1.09
ASIX is the clearest fit if your priority is defensive.
- Beta 0.59, yield 2.8%, current ratio 1.13x
- 2.8% yield, vs BCPC's 0.5%, (1 stock pays no dividend)
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 16.4% revenue growth vs IOSP's -3.7% | |
| Value | Lower P/E (17.9x vs 31.5x), PEG 0.56 vs 2.46 | |
| Quality / Margins | 15.0% margin vs PRM's -26.9% | |
| Stability / Safety | Beta 0.26 vs PRM's 1.09 | |
| Dividends | 2.8% yield, vs BCPC's 0.5%, (1 stock pays no dividend) | |
| Momentum (1Y) | +164.1% vs ASIX's -4.2% | |
| Efficiency (ROA) | 9.4% ROA vs PRM's -6.9%, ROIC 12.2% vs -11.6% |
PRM vs IOSP vs BCPC vs ASIX — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
PRM vs IOSP vs BCPC vs ASIX — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
ASIX leads in 1 of 6 categories
BCPC leads 1 • PRM leads 1 • IOSP leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — PRM and BCPC each lead in 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
IOSP is the larger business by revenue, generating $1.8B annually — 2.5x PRM's $706M. BCPC is the more profitable business, keeping 15.0% of every revenue dollar as net income compared to PRM's -26.9%. On growth, PRM holds the edge at +73.6% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $706M | $1.8B | $1.1B | $1.5B |
| EBITDAEarnings before interest/tax | -$102M | $187M | $267M | $93M |
| Net IncomeAfter-tax profit | -$190M | $114M | $158M | $10M |
| Free Cash FlowCash after capex | $86M | $77M | $182M | -$22M |
| Gross MarginGross profit ÷ Revenue | +56.4% | +27.4% | +36.3% | +7.4% |
| Operating MarginEBIT ÷ Revenue | -20.5% | +8.1% | +21.0% | +0.7% |
| Net MarginNet income ÷ Revenue | -26.9% | +6.4% | +15.0% | +0.7% |
| FCF MarginFCF ÷ Revenue | +12.2% | +4.3% | +17.2% | -1.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | +73.6% | +2.8% | +8.1% | +7.0% |
| EPS Growth (YoY)Latest quarter vs prior year | +22.2% | -6.9% | +10.6% | -167.4% |
Valuation Metrics
ASIX leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 12.7x trailing earnings, ASIX trades at a 64% valuation discount to BCPC's 34.7x P/E. Adjusting for growth (PEG ratio), IOSP offers better value at 0.58x vs ASIX's 6.74x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $5.8B | $2.1B | $5.3B | $615M |
| Enterprise ValueMkt cap + debt − cash | $5.5B | $1.9B | $5.4B | $978M |
| Trailing P/EPrice ÷ TTM EPS | -25.89x | 18.54x | 34.75x | 12.67x |
| Forward P/EPrice ÷ next-FY EPS est. | 20.34x | 17.93x | 31.52x | 15.90x |
| PEG RatioP/E ÷ EPS growth rate | — | 0.58x | 2.71x | 6.74x |
| EV / EBITDAEnterprise value multiple | — | 9.39x | 20.50x | 6.64x |
| Price / SalesMarket cap ÷ Revenue | 8.86x | 1.20x | 5.10x | 0.40x |
| Price / BookPrice ÷ Book value/share | 4.66x | 1.62x | 4.28x | 0.76x |
| Price / FCFMarket cap ÷ FCF | 27.74x | 24.24x | 30.54x | 95.81x |
Profitability & Efficiency
BCPC leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
BCPC delivers a 12.4% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $-16 for PRM. PRM carries lower financial leverage with a 0.03x debt-to-equity ratio, signaling a more conservative balance sheet compared to ASIX's 0.47x. On the Piotroski fundamental quality scale (0–9), BCPC scores 9/9 vs PRM's 5/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | -16.4% | +8.6% | +12.4% | +1.3% |
| ROA (TTM)Return on assets | -6.9% | +6.3% | +9.4% | +0.6% |
| ROICReturn on invested capital | -11.6% | +11.2% | +12.2% | +4.4% |
| ROCEReturn on capital employed | -8.3% | +11.0% | +14.8% | +5.3% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 6 | 9 | 6 |
| Debt / EquityFinancial leverage | 0.03x | 0.07x | 0.15x | 0.47x |
| Net DebtTotal debt minus cash | -$292M | -$203M | $117M | $363M |
| Cash & Equiv.Liquid assets | $326M | $293M | $75M | $20M |
| Total DebtShort + long-term debt | $34M | $90M | $192M | $383M |
| Interest CoverageEBIT ÷ Interest expense | -5.17x | — | 15.23x | 1.38x |
Total Returns (Dividends Reinvested)
PRM leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in PRM five years ago would be worth $29,558 today (with dividends reinvested), compared to $8,730 for ASIX. Over the past 12 months, PRM leads with a +164.1% total return vs ASIX's -4.2%. The 3-year compound annual growth rate (CAGR) favors PRM at 78.1% vs ASIX's -11.2% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +28.9% | +14.7% | +7.2% | +34.3% |
| 1-Year ReturnPast 12 months | +164.1% | +1.4% | +1.3% | -4.2% |
| 3-Year ReturnCumulative with dividends | +464.8% | -7.8% | +24.7% | -30.0% |
| 5-Year ReturnCumulative with dividends | +195.6% | -4.2% | +27.7% | -12.7% |
| 10-Year ReturnCumulative with dividends | +195.6% | +105.2% | +180.9% | +54.4% |
| CAGR (3Y)Annualised 3-year return | +78.1% | -2.7% | +7.6% | -11.2% |
Risk & Volatility
Evenly matched — PRM and BCPC each lead in 1 of 2 comparable metrics.
Risk & Volatility
BCPC is the less volatile stock with a 0.26 beta — it tends to amplify market swings less than PRM's 1.09 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. PRM currently trades 98.5% from its 52-week high vs ASIX's 85.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.09x | 0.70x | 0.26x | 0.59x |
| 52-Week HighHighest price in past year | $36.01 | $92.14 | $183.90 | $26.73 |
| 52-Week LowLowest price in past year | $13.05 | $65.58 | $139.17 | $14.10 |
| % of 52W HighCurrent price vs 52-week peak | +98.5% | +94.0% | +89.7% | +85.3% |
| RSI (14)Momentum oscillator 0–100 | 66.7 | 71.7 | 59.1 | 42.7 |
| Avg Volume (50D)Average daily shares traded | 1.2M | 176K | 171K | 269K |
Analyst Outlook
Evenly matched — BCPC and ASIX each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: PRM as "Buy", IOSP as "Hold", BCPC as "Buy", ASIX as "Buy". Consensus price targets imply 32.8% upside for IOSP (target: $115) vs -3.6% for ASIX (target: $22). For income investors, ASIX offers the higher dividend yield at 2.76% vs BCPC's 0.53%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Buy | Buy |
| Price TargetConsensus 12-month target | $37.00 | $115.00 | $175.50 | $22.00 |
| # AnalystsCovering analysts | 2 | 9 | 10 | 6 |
| Dividend YieldAnnual dividend ÷ price | — | +2.0% | +0.5% | +2.8% |
| Dividend StreakConsecutive years of raises | 0 | 12 | 16 | 0 |
| Dividend / ShareAnnual DPS | — | $1.70 | $0.87 | $0.63 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.7% | 0.0% | +2.0% | +0.3% |
ASIX leads in 1 of 6 categories (Valuation Metrics). BCPC leads in 1 (Profitability & Efficiency). 3 tied.
PRM vs IOSP vs BCPC vs ASIX: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is PRM or IOSP or BCPC or ASIX a better buy right now?
For growth investors, Perimeter Solutions, S.
A. (PRM) is the stronger pick with 16. 4% revenue growth year-over-year, versus -3. 7% for Innospec Inc. (IOSP). AdvanSix Inc. (ASIX) offers the better valuation at 12. 7x trailing P/E (15. 9x forward), making it the more compelling value choice. Analysts rate Perimeter Solutions, S. A. (PRM) a "Buy" — based on 2 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — PRM or IOSP or BCPC or ASIX?
On trailing P/E, AdvanSix Inc.
(ASIX) is the cheapest at 12. 7x versus Balchem Corporation at 34. 7x. On forward P/E, AdvanSix Inc. is actually cheaper at 15. 9x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Innospec Inc. wins at 0. 56x versus AdvanSix Inc. 's 8. 46x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — PRM or IOSP or BCPC or ASIX?
Over the past 5 years, Perimeter Solutions, S.
A. (PRM) delivered a total return of +195. 6%, compared to -12. 7% for AdvanSix Inc. (ASIX). Over 10 years, the gap is even starker: PRM returned +195. 6% versus ASIX's +54. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — PRM or IOSP or BCPC or ASIX?
By beta (market sensitivity over 5 years), Balchem Corporation (BCPC) is the lower-risk stock at 0.
26β versus Perimeter Solutions, S. A. 's 1. 09β — meaning PRM is approximately 311% more volatile than BCPC relative to the S&P 500. On balance sheet safety, Perimeter Solutions, S. A. (PRM) carries a lower debt/equity ratio of 3% versus 47% for AdvanSix Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — PRM or IOSP or BCPC or ASIX?
By revenue growth (latest reported year), Perimeter Solutions, S.
A. (PRM) is pulling ahead at 16. 4% versus -3. 7% for Innospec Inc. (IOSP). On earnings-per-share growth, the picture is similar: Innospec Inc. grew EPS 228. 9% year-over-year, compared to -32. 8% for Perimeter Solutions, S. A.. Over a 3-year CAGR, PRM leads at 21. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — PRM or IOSP or BCPC or ASIX?
Balchem Corporation (BCPC) is the more profitable company, earning 14.
9% net margin versus -31. 6% for Perimeter Solutions, S. A. — meaning it keeps 14. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BCPC leads at 21. 1% versus -30. 8% for PRM. At the gross margin level — before operating expenses — PRM leads at 57. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is PRM or IOSP or BCPC or ASIX more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Innospec Inc. (IOSP) is the more undervalued stock at a PEG of 0. 56x versus AdvanSix Inc. 's 8. 46x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, AdvanSix Inc. (ASIX) trades at 15. 9x forward P/E versus 31. 5x for Balchem Corporation — 15. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for IOSP: 32. 8% to $115. 00.
08Which pays a better dividend — PRM or IOSP or BCPC or ASIX?
In this comparison, ASIX (2.
8% yield), IOSP (2. 0% yield), BCPC (0. 5% yield) pay a dividend. PRM does not pay a meaningful dividend and should not be held primarily for income.
09Is PRM or IOSP or BCPC or ASIX better for a retirement portfolio?
For long-horizon retirement investors, Balchem Corporation (BCPC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
26), 0. 5% yield, +180. 9% 10Y return). Both have compounded well over 10 years (BCPC: +180. 9%, PRM: +195. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between PRM and IOSP and BCPC and ASIX?
Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: PRM is a small-cap high-growth stock; IOSP is a small-cap quality compounder stock; BCPC is a small-cap quality compounder stock; ASIX is a small-cap deep-value stock. IOSP, BCPC, ASIX pay a dividend while PRM does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.